HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

benzyloxycarbonylleucyl-leucyl-leucine aldehyde

proteasome inhibitor
Also Known As:
LLL cpd; MG 132; MG-132; MG132; Z-LLL; Z-Leu-Leu-Leu-al; Z-Leu-Leu-leucinal; ZLLL-CHO; ZLLLal; benzyloxycarbonyl-Leu-Leu-Leu-aldehyde; benzyloxycarbonyl-leucyl-leucyl-leucinal; carbobenzoxy-leucyl-leucyl-leucinal; carbobenzoxyl-leucinyl-leucinyl-leucinal-H; carbobenzyloxy-leucinyl-leucinyl-leucinal
Networked: 530 relevant articles (18 outcomes, 80 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Park, Woo Hyun: 9 articles (04/2012 - 07/2009)
2. Han, Yong Hwan: 6 articles (07/2010 - 07/2009)
3. Yang, Yang: 5 articles (04/2021 - 05/2011)
4. Yu, Le: 5 articles (04/2016 - 06/2008)
5. Zhang, Bin: 4 articles (02/2016 - 02/2011)
6. Wang, Hua-Qin: 4 articles (01/2016 - 11/2009)
7. Lee, Chung Soo: 4 articles (03/2015 - 08/2004)
8. You, Bo Ra: 4 articles (06/2011 - 07/2009)
9. Cho, Chi Hin: 4 articles (02/2010 - 06/2008)
10. Sung, Joseph Jao Yiu: 4 articles (02/2010 - 06/2008)

Related Diseases

1. Neoplasms (Cancer)
2. Carcinoma (Carcinomatosis)
3. Sepsis (Septicemia)
4. Inflammation (Inflammations)
5. Leukemia

Related Drugs and Biologics

1. Proteasome Inhibitors
2. Proteins (Proteins, Gene)
3. lactacystin
4. Protease Inhibitors (Protease Inhibitor)
5. epoxomicin
6. Caspases
7. Paclitaxel (Taxol)
8. Micelles
9. napabucasin
10. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

Related Therapies and Procedures

1. Immunotherapy
2. Aftercare (After-Treatment)
3. Therapeutics
4. Molecular Targeted Therapy
5. Intravenous Injections